RESP Smart Sensor Platform is the leading pulmonary management solution revolutionizing lung health. RESP is the world’s only FDA-cleared biosensor that is clinically validated to detect both coughing, wheezing, ronchi, and other adventitious breathing sounds over time without requiring episodic patient intervention. As demonstrated in 6 ATS publications, RESP can be used continuously and has a much greater sensitivity than intermittent monitoring using an electronic stethoscope. RESP™ offers clinicians a cost-effective, non-invasive and wireless solution that enables early, remote detection of key changes in lung acoustics and ventilation patterns of patients. It also provides continuous recording and identification of respiratory signs and symptoms of interest–allowing a better understanding of the progression of the patient’s respiratory status without auscultation by a clinician. Our clinically validated bioacoustic library of sounds and RESP AI engine is the world’s largest entirely hands-free, clinical-grade dataset enabling Strados Labs to be the standard-bearer of acoustic digital biomarkers for clinical research and respiratory care globally.